| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 06/12/2013 | EP2601956A1 Islets of langerhans transplant using islets of langerhans and adipose tissue derived stem cells |
| 06/12/2013 | EP2601954A1 Therapeutic agent for disease |
| 06/12/2013 | EP2601949A2 Pharmaceutical compositions |
| 06/12/2013 | EP2601946A1 Treatment and prevention of diseases related to oxidative stress |
| 06/12/2013 | EP2601847A1 A nutraceutical compound for treating excess of weight |
| 06/12/2013 | EP2601176A1 Novel salts of saxagrliptin with organic di-acids |
| 06/12/2013 | EP2601175A1 A novel crystalline compound comprising saxagliptin and phosphoric acid |
| 06/12/2013 | EP2600897A2 Methods and compositions for the inhibition of fructokinase |
| 06/12/2013 | EP2600716A1 Methods and compositions for treatment of metabolic disorders |
| 06/12/2013 | EP2178869B1 Indole compounds as an inhibitor of cellular necrosis |
| 06/12/2013 | CN1854135B Heteronuclear compound with dicyandiamide connection and its medicinal use |
| 06/12/2013 | CN1461310B ANtibodies that bind human interleukin-18 and methods of making and using |
| 06/12/2013 | CN103154240A Method of producing pancreatic hormone-producing cells |
| 06/12/2013 | CN103153994A Bicyclic heteroaryl kinase inhibitors and methods of use |
| 06/12/2013 | CN103153981A New crystalline forms of the sodium salt of (4- {4- [5- ( 6 - trifluoromethyl - pyridin- 3 - ylamino ) - pyridin- 2 -yl] -phenyl} - cyclohexyl) -acetic acid |
| 06/12/2013 | CN103153963A Cyclopropane compound |
| 06/12/2013 | CN103153959A 1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as ahr activators |
| 06/12/2013 | CN103153326A Peptides containing tryptophan |
| 06/12/2013 | CN103153301A Methods of treatment |
| 06/12/2013 | CN103153296A Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists |
| 06/12/2013 | CN103153288A Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin |
| 06/12/2013 | CN103146560A Health-care vinegar and preparation method thereof |
| 06/12/2013 | CN103146559A Nutritive health-care wine and preparation method thereof |
| 06/12/2013 | CN103146532A Black tartary buckwheat red rice flavone wine and production method thereof |
| 06/12/2013 | CN103145865A Preparation method and application of stereum hirsutum mycelium polysaccharide |
| 06/12/2013 | CN103145773A Crystalline solvates and complexes of (IS) -1, 5-anhydro-L-C- (3- ( (phenyl) methyl) phenyl) -D-glucitol derivatives with amino acids as SGLT2 inhibitors for the treatment of diabetes |
| 06/12/2013 | CN103145739A Pyrimido thiazole type compounds with anti-inflammatory effect and application thereof in preparation of anti-inflammatory medicaments |
| 06/12/2013 | CN103145738A Imidazo [2,1-b] thiayole derivatives as SIRTUIN modulating compounds |
| 06/12/2013 | CN103145712A Substituted 8-[6-amino-3-pyridyl]xanthenes |
| 06/12/2013 | CN103145706A Imidazopyridine compound with anti-inflammatory action and application thereof to preparation of anti-inflammatory medicament |
| 06/12/2013 | CN103145704A 1,4-dihydro-1,8-nalidixic acid derivatives, their pharmaceutical composition and use of the pharmaceutical composition |
| 06/12/2013 | CN103145674A Crystal forms of 7-hydroxyl isoflavone, preparation methods thereof, pharmaceutical composition of methods and purpose |
| 06/12/2013 | CN103145663A (S)-2-(2,3-dihydrobenzofuran-3-radical) acetic acid derivative as well as preparation method and application thereof in medicines |
| 06/12/2013 | CN103145662A N-substituted animobutyrolactone derivatives and uses thereof |
| 06/12/2013 | CN103145620A Cb1 receptor modulators |
| 06/12/2013 | CN103145579A Sodium pantothenate compound, and composition preparation containing it |
| 06/12/2013 | CN103143117A Hpyerglycemic foot patch |
| 06/12/2013 | CN103143018A Oral formulations containing metformin and alpha-glycosidase inhibitor, and preparation method thereof |
| 06/12/2013 | CN103143001A Bone collagen high calcium tablet |
| 06/12/2013 | CN103142992A Preparation method of compound amino acid injection 15 dipeptide |
| 06/12/2013 | CN103142975A Medicament for reducing blood fat |
| 06/12/2013 | CN103142952A Medicament for treating type-2 diabetes |
| 06/12/2013 | CN103142927A Traditional Chinese medicine formula for preserving health and treating multiple diseases |
| 06/12/2013 | CN103142922A Lactagogue and sliming confinement soup prescription and preparation method thereof |
| 06/12/2013 | CN103142914A Traditional Chinese medicine for lowering blood sugar |
| 06/12/2013 | CN103142877A Traditional Chinese medicine composition for treating obesity and preparation method thereof |
| 06/12/2013 | CN103142871A Obesity treatment medicine and its preparation method |
| 06/12/2013 | CN103142868A Medicine for inhibiting protein-tyrosine-phosphatase-1B |
| 06/12/2013 | CN103142844A Pharmaceutical composition for treating diabetic nephropathy |
| 06/12/2013 | CN103142842A Traditional Chinese medicine for treating diabetes mellitus |
| 06/12/2013 | CN103142838A Chinese medicinal composition for treating hyperlipemia and method for preparing same |
| 06/12/2013 | CN103142831A Pharmaceutical composition for treating diabetes, and preparation method thereof |
| 06/12/2013 | CN103142830A Nano high-selenium eyesight-improving snake gall liquor |
| 06/12/2013 | CN103142806A Traditional Chinese medicine for treating diabetic nephropathy and preparation method thereof |
| 06/12/2013 | CN103142780A Extract of iris lactea seed or iris lactea seed skin as well as preparation method and purpose of extract |
| 06/12/2013 | CN103142765A Total nutrient ganoderma lucidum snake wine containing rich selenium germanium nano elements and vitamins |
| 06/12/2013 | CN103142720A Application of black raspberry extract in preparing anti-diabetic medicine |
| 06/12/2013 | CN103142706A Application of perfoliote knotweed herb |
| 06/12/2013 | CN103142704A Functional white wine for treating constipation, insomnia and gout, lowering blood sugar and tonifying yang |
| 06/12/2013 | CN103142685A Method for extraction of total flavonoid aglycones from hickory leaves |
| 06/12/2013 | CN103142681A Flemingia philippinensis total flavonoids and beta-cyclodextrin clathrate compound and preparation method thereof |
| 06/12/2013 | CN103142675A Blood sugar reducing traditional Chinese medicinal herb |
| 06/12/2013 | CN103142668A Anti-fatigue Miaoliyuan capsule and preparation method thereof |
| 06/12/2013 | CN103142661A Preparation method of inonqqus obliquus water-extract fine powder |
| 06/12/2013 | CN103142657A Application of bacteroides fragilis in preparing composition for preventing and treating hypercholesteremia |
| 06/12/2013 | CN103142647A Lanthanum hydroxide therapeutical effects on hyperphosphatemia and relative diseases |
| 06/12/2013 | CN103142642A Calcitriol and calcium carbonate suspension granule and preparation method thereof |
| 06/12/2013 | CN103142641A Calcium carbonate-vitamin K pharmaceutical preparation and preparation method thereof |
| 06/12/2013 | CN103142633A Compound amino acid capsule including eight amino acids and eleven vitamins |
| 06/12/2013 | CN103142600A Weekly administration of dipeptidyl peptidase inhibitors |
| 06/12/2013 | CN103142599A Treatment of T-cell mediated diseases |
| 06/12/2013 | CN103142596A Medicinal composition containing telmisartan and pitavastatin |
| 06/12/2013 | CN103142568A Calcium acetate-vitamin K pharmaceutical preparation and preparation method thereof |
| 06/12/2013 | CN103142557A Polymannuronate sulfate slow release capsule and preparation method thereof |
| 06/12/2013 | CN103142556A Polysaccharide sulfate sustained-release capsule and preparation method thereof |
| 06/12/2013 | CN103142555A Alfacalcidol sustained-release capsule and preparation method thereof |
| 06/12/2013 | CN103142554A Calcitriol controlled-release capsule and preparation method thereof |
| 06/12/2013 | CN103142553A Calcitriol sustained-release capsule and preparation method thereof |
| 06/12/2013 | CN103142552A Lovastatin enteric coated sustained-release pellet capsule and preparation method thereof |
| 06/12/2013 | CN103142549A Mannose ester enteric capsule and preparation method thereof |
| 06/12/2013 | CN103142547A Calcitriol enteric capsule and preparation method thereof |
| 06/12/2013 | CN103142546A Calcitriol capsule and preparation method thereof |
| 06/12/2013 | CN103142540A PGMS (Propylene Glycol Mannate Sulfate) controlled-release tablet and preparation method thereof |
| 06/12/2013 | CN103142539A Alginic sodium diester controlled-release tablet and preparation method thereof |
| 06/12/2013 | CN103142538A PGMS (Propylene Glycol Mannate Sulfate) enteric tablet and preparation method thereof |
| 06/12/2013 | CN103142537A Calcitriol slow-release preparation troche |
| 06/12/2013 | CN103142536A Calcitriol enteric tablet and preparation method thereof |
| 06/12/2013 | CN103142535A Alginic sodium diester enteric tablet and preparation method thereof |
| 06/12/2013 | CN103142534A Calcitriol controlled-release tablet and preparation method thereof |
| 06/12/2013 | CN103142524A Calcitriol tablet and preparation method thereof |
| 06/12/2013 | CN103142521A Glibenclamide tablet and preparation method thereof |
| 06/12/2013 | CN103142519A Levocarnitine tablets and preparation method thereof |
| 06/12/2013 | CN103142518A Alogliptin liposome solid preparation as well as preparation method and application thereof |
| 06/12/2013 | CN103142504A PGMS (Propylene Glycol Mannate Sulfate) sustained-release granule and preparation method thereof |
| 06/12/2013 | CN103142503A Alfacalcidol sustained-release granule and preparation method thereof |
| 06/12/2013 | CN103142502A Calcitriol sustained-release granule and preparation method thereof |
| 06/12/2013 | CN103142501A Calcitriol pellet and preparation method thereof |
| 06/12/2013 | CN103142498A Calcitriol enteric granule and preparation method thereof |
| 06/12/2013 | CN103142496A Calcitriol controlled-release granule and preparation method thereof |
| 06/12/2013 | CN103142495A Calcitriol suspension granule and preparation method thereof |